FFA
SER icon

Farther Finance Advisors’s Serina Therapeutics SER Stock Holding History

Farther Finance Advisors’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 5964
2026
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 5740

Other funds holding SER

PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

Farther Finance Advisors's SER Position: Q2 2026 in Review

Farther Finance Advisors held its Serina Therapeutics (SER) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5964.

Farther Finance Advisors first reported a position in SER in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Farther Finance Advisors held 1 share of Serina Therapeutics worth $2 as of Q2 2026.
  • Farther Finance Advisors left its Serina Therapeutics share count unchanged in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5964 holding.
  • Farther Finance Advisors first reported a position in Serina Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.